Cellectar Biosciences, Inc.
CLRBW
CLRBW was delisted on the 20th of August, 2019.
4 hedge funds and large institutions have $248K invested in Cellectar Biosciences, Inc. in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
428% more capital invested
Capital invested by funds: $47K → $248K (+$201K)
100% more funds holding
Funds holding: 2 → 4 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$100K |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$32.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$158 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $219K | +$100K | +164,651 | +252% |
|
|
CAM
2
Cormorant Asset Management
Boston,
Massachusetts
| $29K | +$32.3K | +52,999 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| – | +$158 | +259 | New |
|
CLRBW Hedge Fund Activity: Q2 2016 in Review
4 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. (CLRBW) for Q2 2016, worth a combined $248K — up 428% from $47K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CLRBW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, adding an estimated $100K.
- 4 institutional investors held Cellectar Biosciences, Inc. (CLRBW) as of Q2 2016, up from 2 in Q1 2016.
- Funds reported $248K of Cellectar Biosciences, Inc. stock for Q2 2016, up 428% quarter-over-quarter.
- 2 funds opened new Cellectar Biosciences, Inc. positions in Q2 2016 and 0 closed out, a net change of +2 holders.
- The largest Cellectar Biosciences, Inc. buyer in Q2 2016 was Sabby Management, an estimated $100K added.
Based on aggregated 13F filings for Q2 2016.